Company research
Universe Pharmaceuticals INC
CIK 1809616Updated Sep 25, 2026
SecurityUPC · NASDAQ · equity
UPC price & chart
Loading TradingView…
NASDAQ:UPC on TradingView ↗In the news
No coverage from other publishers is available.
Seeking Alpha
Financials
FY 2025 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| ASSETS | ||||
| AssetsUSD | 69,303,440,000Source | 67,953,393Source | 53,287,032Source | 59,539,875Source |
| Property, Plant and Equipment, NetUSD | 3,583,553,000Source | 3,568,050Source | 3,699,965Source | 4,250,638Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 296,785,000Source | 262,878Source | 148,584Source | 157,451Source |
| Current assets: | ||||
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 13,008,117,000Source | 12,905,821Source | 10,667,603Source | 15,183,890Source |
| Inventory, NetUSD | 2,193,179,000Source | 1,737,054Source | 3,343,266Source | 2,206,488Source |
| Assets, CurrentUSD | 53,603,675,000Source | 51,637,784Source | 36,810,218Source | 41,505,680Source |
| Prepaid Expense and Other Assets, CurrentUSD | 39,937,000Source | 852,417Source | 626,241Source | — |
| LIABILITIES AND EQUITY | ||||
| LiabilitiesUSD | 13,173,930,000Source | 22,450,452Source | — | — |
| Stockholders’ equity: | ||||
| Common Stock, Value, IssuedUSD | 6,337,553,000Source | 482,400Source | 67,969Source | 67,969Source |
| Additional Paid in CapitalUSD | — | — | — | 29,279,159Source |
| Retained Earnings (Accumulated Deficit)USD | -13,843,623,000Source | -10,171,568Source | 10,159,304Source | 16,322,365Source |
| Accumulated Other Comprehensive Income (Loss), Net of TaxUSD | -1,813,522,000Source | -1,112,146Source | -2,413,266Source | -1,666,705Source |
| Stockholders' Equity Attributable to ParentUSD | 56,129,510,000Source | 45,502,941Source | 39,532,701Source | 46,442,323Source |
| Additional Paid in Capital, Common StockUSD | 63,009,567,000Source | 53,864,720Source | 29,279,159Source | — |
| Liabilities and EquityUSD | 69,303,440,000Source | 67,953,393Source | 53,287,032Source | 59,539,875Source |
| Current liabilities: | ||||
| Liabilities, CurrentUSD | 13,173,930,000Source | 20,312,969Source | 13,754,331Source | 13,097,552Source |
| Accounts Payable, CurrentUSD | 1,669,785,000Source | 4,914,762Source | 4,585,285Source | 3,075,393Source |
| Additional Financial Items | ||||
| Accounts Receivable, after Allowance for Credit LossUSD | 6,600,000Source | 12,800,000Source | 6.5Source | 15,183,890Source |
| Long-term Debt, Current MaturitiesUSD | 2,107,038,000Source | — | — | — |
| Short-term InvestmentsUSD | — | — | 13,219,005Source | 13,148,594Source |
cash flow · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Cash flows from operating activities: | ||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | — | -8,736,566Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||
| Depreciation, Depletion and AmortizationUSD | 517,431,000Source | 485,734Source | 508,785Source | 533,949Source |
| Changes in operating assets and liabilities: | ||||
| Increase (Decrease) in Accounts ReceivableUSD | 168,958,000Source | 1,547,834Source | -4,718,118Source | 1,549,312Source |
| Increase (Decrease) in InventoriesUSD | 474,633,000Source | -1,643,131Source | 1,183,823Source | -16,586Source |
| Increase (Decrease) in Accounts PayableUSD | -3,132,705,000Source | 143,747Source | 1,641,426Source | -1,896,621Source |
| Deferred Income Tax Expense (Benefit)USD | — | 606,704Source | 679,586Source | -605,278Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | -5,052,319,000Source | -9,506,683Source | 1,120,082Source | -1,312,346Source |
| Cash flows from investing activities: | ||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | -341,807,000Source | -361,285Source | -44,169Source | -3,908,105Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | 266,771,000Source | 208,320Source | 44,169Source | 93,703Source |
| Cash flows from financing activities: | ||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | 9,726,130,000Source | 33,954,325Source | -1,390,646Source | 3,317,943Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | 4,094,332,000Source | 24,212,446Source | -426,211Source | -2,366,450Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | 33,592,025,000Source | 29,497,693Source | 5,285,247Source | 5,711,458Source |
| Supplemental disclosure of cash flow information: | ||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | 289,385,000Source | 304,516Source | 190,184Source | 199,852Source |
| Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash EquivalentsUSD | -237,672,000Source | 126,089Source | -111,478Source | -463,942Source |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 43,253,000Source | 11,700Source | 5,098Source | 5,030Source |
| DepreciationUSD | 474,178,000Source | 474,034Source | 503,687Source | 528,919Source |
| Gain (Loss) on Disposition of AssetsUSD | — | — | -114Source | 983Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | -2,948,000Source | -3,958Source | — | — |
| General and Administrative ExpenseUSD | 3,747,705,000Source | 2,889,652Source | 2,199,657Source | 2,602,624Source |
| Income (Loss) from Equity Method InvestmentsUSD | 65,058,000Source | 31,942Source | 31,072Source | 38,588Source |
| Income Tax Expense (Benefit)USD | — | 606,704Source | 2,313,487Source | 752,419Source |
| InterestExpenseNonoperatingUSD | 232,041,000Source | 278,172Source | — | — |
| Net Income (Loss) Attributable to ParentUSD | -3,672,055,000Source | -8,727,298Source | -6,163,061Source | -8,736,566Source |
| Nonoperating Income (Expense)USD | -756,136,000Source | -100,754Source | — | — |
| Operating ExpensesUSD | 9,217,088,000Source | 14,091,742Source | 13,841,908Source | 29,330,134Source |
| Other Nonoperating Income (Expense)USD | -108,044,000Source | 145,476Source | -322,800Source | -545,349Source |
| Other Operating Income (Expense), NetUSD | — | — | -235,614Source | 48,940Source |
| Proceeds from Issuance of Common StockUSD | 15,000,000,000Source | 24,999,992Source | — | — |
income statement · annual statements
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|
| Total RevenueUSD | 17,858,732,000Source | 23,024,458Source | 32,308,735Source | 40,143,151Source |
| Cost of RevenueUSD | — | — | — | 16,154,974Source |
| Operating Income (Loss)USD | -2,915,919,000Source | -8,019,840Source | -3,526,774Source | — |
| Other Nonoperating Income (Expense)USD | -108,044,000Source | 145,476Source | -322,800Source | -545,349Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | -3,672,055,000Source | -8,120,594Source | -3,849,574Source | -7,984,147Source |
| Income Tax Expense (Benefit)USD | — | 606,704Source | 2,313,487Source | 752,419Source |
| Net Income (Loss) Attributable to ParentUSD | -3,672,055,000Source | -8,727,298Source | -6,163,061Source | -8,736,566Source |
| Earnings Per Share, BasicUSD per share | -8.06Source | -626.96Source | -1.7Source | -0.4Source |
| Earnings Per Share, DilutedUSD per share | -8.06Source | -626.96Source | -1.7Source | -0.4Source |
| Weighted Average Number of Shares Outstanding, Basicshares | 455,871Source | 13,920Source | 3,625,000Source | 21,750,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | 455,871Source | 13,920Source | 3,625,000Source | 21,750,000Source |
| Interest Expense (non-operating)USD | 232,041,000Source | 278,172Source | — | — |
| Additional Financial Items | ||||
| Amortization of Intangible AssetsUSD | 43,253,000Source | 11,700Source | 5,098Source | 5,030Source |
| Current Income Tax Expense (Benefit)USD | — | — | 685,937Source | 1,357,697Source |
| General and Administrative ExpenseUSD | 3,747,705,000Source | 2,889,652Source | 2,199,657Source | 2,602,624Source |
| Gross ProfitUSD | 6,301,169,000Source | 6,071,902Source | 10,315,134Source | 21,891,336Source |
| Income (Loss) from Equity Method InvestmentsUSD | 65,058,000Source | 31,942Source | 31,072Source | 38,588Source |
| Interest ExpenseUSD | 289,385,000Source | — | 156,788Source | 162,400Source |
| Investment Income, NetUSD | — | — | 38,530Source | — |
| Net Investment IncomeUSD | — | — | 31,072Source | 38,588Source |
| Nonoperating Income (Expense)USD | -756,136,000Source | -100,754Source | — | — |
| Operating ExpensesUSD | 9,217,088,000Source | 14,091,742Source | 13,841,908Source | 29,330,134Source |
| Other Operating Income (Expense), NetUSD | — | — | -235,614Source | 48,940Source |
| Research and Development ExpenseUSD | 671,761,000Source | 3,031,115Source | 4,858,548Source | 7,644,375Source |
| Selling ExpenseUSD | 4,797,622,000Source | 8,170,975Source | 6,783,703Source | 19,083,135Source |